Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application
暂无分享,去创建一个
I. Buño | J. Díez-Martín | C. Martínez-Laperche | M. Kwon | R. Bailén | A. Navarro-Bailón | A. Escudero | G. Oarbeascoa | J. Suárez-González | D. Carbonell | P. Muñiz | M. Chicano
[1] I. Buño,et al. Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation. , 2020, Haematologica.
[2] H. Marquart,et al. Highly sensitive chimerism detection in blood is associated with increased risk of relapse after allogeneic hematopoietic cell transplantation in childhood leukemia , 2019, Pediatric transplantation.
[3] H. Shike,et al. Personalized Chimerism Test that Uses Selection of Short Tandem Repeat or Quantitative PCR Depending on Patient's Chimerism Status. , 2019, The Journal of molecular diagnostics : JMD.
[4] I. Buño,et al. Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] A. Ganser,et al. Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation , 2018, Bone Marrow Transplantation.
[6] M. Piris,et al. Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis , 2018, Leukemia.
[7] A. Mackensen,et al. Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation , 2017, Blood Cancer Journal.
[8] A. Liou,et al. Early mixed chimerism‐based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia , 2017, Pediatric blood & cancer.
[9] E. Miranda,et al. Chimerism interpretation with a highly sensitive quantitative PCR method: 6 months median latency before chimerism drop below 0.1% , 2016, Bone Marrow Transplantation.
[10] Jennifer R. Zitzner,et al. Real-time qPCR for chimerism assessment in allogeneic hematopoietic stem cell transplants from unrelated adult and double umbilical cord blood. , 2015, Human immunology.
[11] J. Golmard,et al. Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia , 2015, Bone Marrow Transplantation.
[12] A. Mackensen,et al. Monitoring of Hematopoietic Chimerism by Real-Time Quantitative PCR of Micro Insertions/Deletions in Samples with Low DNA Quantities , 2015, Transfusion Medicine and Hemotherapy.
[13] J. Snowden,et al. Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Wo , 2015, British journal of haematology.
[14] I. Buño,et al. Achievement of early complete donor chimerism in CD25+-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation. , 2015, Experimental hematology.
[15] C. Niemeyer,et al. Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow? , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] J. Y. Kim,et al. Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion/deletion polymorphisms. , 2014, The Journal of molecular diagnostics : JMD.
[17] B. Dörken,et al. Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] I. Buño,et al. Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells , 2014, Bone Marrow Transplantation.
[19] Chun Wang,et al. Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation , 2014, International Journal of Hematology.
[20] F. Frommlet,et al. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation , 2012, Leukemia.
[21] T. Lion,et al. Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation , 2012, Leukemia.
[22] P. Ljungman,et al. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] A. Kiani,et al. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation , 2009, Haematologica.
[24] Y. Heike,et al. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] C. Vnencak-Jones,et al. Comparison of peripheral blood and bone marrow samples for detection of post transplant mixed chimerism , 2008, Bone Marrow Transplantation.
[26] D. Blaise,et al. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. , 2007, Haematologica.
[27] Edward A Copelan,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[28] M. Maris,et al. Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[29] A. Svejgaard,et al. Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[30] A. Piekarska,et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease , 2005, Bone Marrow Transplantation.
[31] R. Storb,et al. Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning. , 2005, Blood reviews.
[32] I. Buño,et al. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms , 2005, Leukemia.
[33] I. Buño,et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. , 2005, Haematologica.
[34] T. Klingebiel,et al. How and when should we monitor chimerism after allogeneic stem cell transplantation? , 2005, Bone Marrow Transplantation.
[35] D. Kukuruga,et al. Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival , 2004, Leukemia.
[36] C. Thiede. Diagnostic Chimerism Analysis After Allogeneic Stem Cell Transplantation , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[37] I. Buño,et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms , 2003, Leukemia.
[38] M. Bernard,et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. , 2002, Blood.
[39] O. Ringdén,et al. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation , 2001, Leukemia.
[40] S Mackinnon,et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[41] M. Remberger,et al. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. , 2001, Transplantation.
[42] T. Lion,et al. Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation , 2001, Leukemia.
[43] T. Lion,et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection , 1999, Leukemia.
[44] N. Young,et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. , 1999, Blood.
[45] M. Florek,et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection , 1999, Bone Marrow Transplantation.
[46] J. Bourhis,et al. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. , 1992, Blood.
[47] C. E. Ford,et al. Cytological Identification of Radiation-Chimæras , 1956, Nature.